MediWound Ltd. (MDWD)

MediWound Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	4.34	4.8	9.16	11.87	33.9	11.05
Short-Term Investments	31	48.34	34.01	29.68	-	-
Cash & Short-Term Investments	35.34	53.14	43.16	41.54	33.9	11.05
Cash Growth	8.96%	23.12%	3.90%	22.56%	206.85%	-48.38%
Accounts Receivable	1.69	1.62	4.8	3.7	9.33	2.13
Other Receivables	1.8	0.75	1.05	0.72	0.36	0.14
Receivables	3.49	2.37	5.85	4.42	9.7	2.27
Inventory	4.12	4.09	2.69	2.85	1.96	1.2
Prepaid Expenses	-	0.36	0.46	0.72	0.29	0.44
Other Current Assets	-	-	-	0.17	-	-
Total Current Assets	42.95	59.96	52.16	49.7	45.84	14.95
Property, Plant & Equipment	28.39	25.79	20.8	15.93	3.58	4.03
Other Intangible Assets	-	0.03	0.1	0.17	0.23	0.3
Other Long-Term Assets	0.54	0.47	0.44	0.67	0.36	0.47
Total Assets	71.88	86.26	73.5	66.46	50.02	19.74

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.63	3.61	4.1	4.22	5.66	4.69
Accrued Expenses	-	7.17	4.06	4.75	3.2	2.3
Current Portion of Leases	-	0.62	0.42	0.36	0.53	0.6
Current Unearned Revenue	-	1.43	0.65	0.15	0.18	0.76
Other Current Liabilities	10.92	12.88	17.32	8.64	2.49	2.37
Total Current Liabilities	18.54	25.71	26.54	18.13	12.06	10.72
Long-Term Leases	8.61	8.15	6.51	6.35	0.85	1.39
Long-Term Unearned Revenue	8.78	8.29	8.89	7.68	7.45	8
Pension & Post-Retirement Benefits	0.3	0.47	0.4	0.46	0.36	0.29
Other Long-Term Liabilities	-	-	-	2.26	18.39	3.92
Total Liabilities	36.24	42.62	42.34	34.86	39.1	24.33

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.26	0.26	0.22	0.18	0.14	0.08
Additional Paid-In Capital	274.67	272.33	236	206.25	178.88	143.87
Retained Earnings	-239.27	-228.93	-205.05	-174.82	-168.11	-148.51
Comprehensive Income & Other	-0.02	-0.03	-0.01	-0.02	-0.01	-0.02
Shareholders' Equity	35.64	43.63	31.15	31.6	10.91	-4.58
Total Liabilities & Equity	71.88	86.26	73.5	66.46	50.02	19.74

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	8.61	8.78	6.93	6.71	1.38	1.99
Net Cash (Debt)	26.74	44.37	36.23	34.83	32.52	9.06
Net Cash Growth	9.73%	22.45%	4.02%	7.11%	259.07%	-52.57%
Net Cash Per Share	2.16	3.90	3.64	3.86	6.52	2.33
Filing Date Shares Outstanding	12.91	12.85	10.81	9.26	9.2	4.64
Total Common Shares Outstanding	12.91	12.84	10.79	9.22	7.24	3.9
Working Capital	24.41	34.26	25.62	31.57	33.78	4.23
Book Value Per Share	2.76	3.40	2.89	3.43	1.51	-1.18
Tangible Book Value	35.64	43.6	31.05	31.43	10.68	-4.88
Tangible Book Value Per Share	2.76	3.40	2.88	3.41	1.48	-1.25
Machinery	-	22.54	17.63	12.99	5.55	5.2
Leasehold Improvements	-	3.97	3.45	3.38	3.28	3.14

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 19, 2026

Data Sources Report a data error